News
50mon MSN
GLP-1 drugs such as Lilly’s Mounjaro and Novo’s Ozempic linked to lower cancer risk: study
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug market, revolutionizing diabetes and obesity treatment with its blockbuster ...
After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback